The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging — VialBase Research
high
- GHK-Cu levels decline with aging from 200 ng/mL to 80 ng/mL
- Demonstrates anti-cancer gene expression effects
- Potent antioxidant and anti-inflammatory properties
Summary
This review examines GHK-Cu’s role in preventing oxidative stress and age-related degenerative conditions. It documents the age-related decline in circulating GHK levels and proposes that restoring GHK-Cu may counteract multiple aging processes simultaneously.
Key Findings
- Plasma GHK levels decline from ~200 ng/mL at age 20 to ~80 ng/mL by age 60
- Age-related GHK decline correlates with reduced tissue repair capacity
- GHK-Cu activates antioxidant genes: superoxide dismutase, glutathione peroxidase
- Suppresses genes associated with tissue destruction and inflammation
- Gene expression analysis suggests anti-cancer properties (suppresses metastasis-related genes)
- Copper delivery function may support numerous copper-dependent enzymes
Methodology
Review article integrating biochemical research, gene expression microarray data (Broad Institute), and clinical observation data spanning several decades of GHK-Cu research. Includes analysis of the Connectivity Map gene expression database.
Limitations
- Theoretical framework connecting gene expression to clinical outcomes needs validation
- Anti-cancer claims based on gene expression patterns, not clinical oncology data
- Most evidence from in-vitro models
- Plasma GHK level measurements have limited supporting data
- Author conflict of interest (patent holder)
Relevance to Content
The age-related decline narrative is powerful for content: “your body produces less GHK-Cu as you age, and supplementation may help restore youthful repair capacity.” Useful for anti-aging content positioning GHK-Cu alongside other longevity interventions. The antioxidant angle connects to broader wellness content.